@encodelp Encode Ideas
Encode Ideas posts on X about $xene, $nbix, $dcth, $vtyx the most. They currently have [-----] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.
Engagements: [--] #
- [--] Week [---] -45%
- [--] Month [-----] -44%
- [--] Months [------] +200%
- [--] Year [------] -15%
Mentions: [--] #
- [--] Week [--] +25%
- [--] Month [--] -13%
- [--] Months [--] +43%
- [--] Year [--] +72%
Followers: [-----] #
- [--] Week [-----] +0.05%
- [--] Month [-----] +0.21%
- [--] Months [-----] -6.60%
- [--] Year [-----] -18%
CreatorRank: undefined #
Social Influence
Social category influence stocks 52.63% cryptocurrencies 18.42% finance 6.58% currencies 1.32% countries 1.32% vc firms 1.32%
Social topic influence $xene 25%, $nbix 15.79%, $dcth 15.79%, $vtyx 9.21%, $cgon 9.21%, $tara 9.21%, $ovid 7.89%, $rvxcf 6.58%, $nktr 6.58%, gain 5.26%
Top accounts mentioned or mentioned by @biotechch @jnap5c @jeangabcrevier @wardleworld @gantosj @chamath @perimetermed @alphacognition @fincapital @bymadeleinea @propthinker @amaymd @excag @thebiohunter @thephiloinvest @reignots
Top assets mentioned Xenon Pharmaceuticals Inc (XENE) Neurocrine Biosciences, Inc. (NBIX) Ventyx Biosciences, Inc. (VTYX) CG Oncology, Inc. (CGON) Taraxa (TARA) Gain Therapeutics, Inc. (GANX) ImmunityBio, Inc. Common Stock (IBRX) Sarepta Therapeutics, Inc. (SRPT) Eli Lilly and Company (LLY) RenovoRx, Inc. (RNXT) Liquidia Corporation Common Stock (LQDA) United Therapeutics, Corp. (UTHR) Tandem Diabetes Care, Inc. (TNDM) Insulet, Corp. (PODD) Measurable Data Token (MDT) Novo-Nordisk (NVO) Immunocore Holdings Limited (IMCR) COMPASS Pathways plc (CMPS) Acadia Pharmaceuticals Inc. (ACAD) Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) Tourmaline Bio, Inc. (TRML) Acumen Pharmaceuticals, Inc. (ABOS) Alnylam Pharmaceuticals, Inc. (ALNY) Pfizer, Inc. (PFE) Hologic, Inc. (HOLX) Basilisk (BSX) Biogen Inc (BIIB) Viking Therapeutics, Inc (VKTX) Vertex Protocol (VRTX) Anebulo Pharmaceuticals, Inc. (ANEB) AltLayer (ALT) Amgen, Inc. (AMGN) LYRA (LYRA) Soleno Therapeutics, Inc. Common Stock (SLNO) NovoCure Limited Ordinary Shares (NVCR)
Top Social Posts
Top posts by engagements in the last [--] hours
"$VRNA novel MOA PDE3/4 inhibitor for COPD. Ph3 data mid-22. Good cash well-held big market. Gil Aharon of Rosalind highlights as a name they like & own. Feels strongly they hit on FEV1 less certain on QOL regardless feels affordable. Start [--] min mark https://www.encodelp.com/podcasts/rosalind-advisors/ https://www.encodelp.com/podcasts/rosalind-advisors/"
X Link 2021-12-13T19:51Z [----] followers, [--] engagements
"Big Ideas Early Data Imminent Results: Ovid & Gain $OVID $GANX $ACAD $MSCLF https://www.encodelp.com/coverage-updates/big-ideas-early-data-imminent-results-ovid-gain/ https://www.encodelp.com/coverage-updates/big-ideas-early-data-imminent-results-ovid-gain/"
X Link 2025-12-11T14:45Z [----] followers, [----] engagements
"Prediction Payoff: Ventyx Acquired Plus Updates On Entera & Gain $VTYX $ENTX $GANX $ZVSA. Please note: Gain did in fact release patient-level data at the back end of its webinar slide deck (slide 32). Our mistake. https://www.encodelp.com/coverage-universe/pre-jpm26/ https://www.encodelp.com/coverage-universe/pre-jpm26/"
X Link 2026-01-09T14:43Z [----] followers, [----] engagements
"Ventyx: Celebrate a CRP Hit & Dismiss an Obesity Miss $VTYX $KNSA $TRML https://www.encodelp.com/coverage-universe/ventyx-celebrate-a-crp-hit-dismiss-an-obesity-miss/ https://www.encodelp.com/coverage-universe/ventyx-celebrate-a-crp-hit-dismiss-an-obesity-miss/"
X Link 2025-10-29T13:16Z [----] followers, [----] engagements
"From Aduhelm's Ashes: Two Affordable Alzheimer Names Targeting Toxic Oligomers $ABOS $PMN https://www.encodelp.com/coverage-universe/from-aduhelms-ashes-two-affordable-alzheimer-names-targeting-toxic-oligomers/ https://www.encodelp.com/coverage-universe/from-aduhelms-ashes-two-affordable-alzheimer-names-targeting-toxic-oligomers/"
X Link 2026-01-30T15:25Z [----] followers, [---] engagements
""Can Satellos (MSCL) Play Well With Sarepta (SRPT)" $MSCL $MSCLF $SRPT @BiotechCH https://www.encodelp.com/uncategorized/june-update/ https://www.encodelp.com/uncategorized/june-update/"
X Link 2024-06-24T16:46Z [----] followers, [----] engagements
"With Biotech Risk-On Let's Revisit Gain & Satellos $GANX $MSCLF $MSCL.TO $SRPT https://www.encodelp.com/coverage-universe/with-biotech-risk-on-lets-revisit-gain-satellos/ https://www.encodelp.com/coverage-universe/with-biotech-risk-on-lets-revisit-gain-satellos/"
X Link 2025-09-25T13:14Z [----] followers, [----] engagements
"$XENE $NBIX enter into exclusive license agreement for XEN901. Really more of a Nav1.6 agreement (and Nav1.2). Makes sense for $XENE they can now focus on their later-stage Kv7 products XEN1101 & 496"
X Link 2019-12-02T13:02Z [----] followers, [--] engagements
"In our initiation report we assumed XEN1101 would be the asset $XENE eventually partnered but based on today's $NBIX Nav1.6 deal and comments from the call it seems like $XENE is 'all-in' on Kv7. No plans to partner 1101"
X Link 2019-12-02T13:55Z [----] followers, [--] engagements
"On their $NBIX deal call $XENE hinted at indication expansion for XEN1101. Might we get this news next week at JPM"
X Link 2020-01-09T16:41Z [----] followers, [--] engagements
"So with $XENE selling 3.2M shares off ATM for net proceeds of $49M their S/O will be 32M (reminder BVF holds 1M prefs and $NBIX bought 1.4M in XEN901 deal) and pro-forma cash will be $175-$190M"
X Link 2020-01-13T13:35Z [----] followers, [--] engagements
"$XENE had raised $100M in Dec/Jan thru $NBIX deal & ATM and now coming back for more"
X Link 2020-01-22T21:19Z [----] followers, [--] engagements
"$NBIX reiterates plans to file IND for Nav1.6 AED licensed from $XENE in mid-20 and start Ph2 study 2H20. Upon FDA acceptance of the IND $XENE will receive $25M milestone"
X Link 2020-02-04T22:11Z [----] followers, [--] engagements
"$RVXCF $200M cap failed Ph3 no cash and some debt. Lifted recently off BDT news but almost certainly more clinical work needed = more cash = more dilution"
X Link 2020-02-07T15:54Z [----] followers, [--] engagements
"$RVXCF $RVX.TO desperately needs capital so no surprise to see this PR today "Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research""
X Link 2020-03-23T13:09Z [----] followers, [--] engagements
"1) $ABUS one of my first big wins in the market was $TKMR. Traded/owned it pre $ALNY settlement during Ebola frenzy and Oncore merger. IMHO $ABUS $TKMR has always undervalued its LNP delivery technology"
X Link 2020-07-24T13:58Z [----] followers, [--] engagements
"wouldn't be surprising to see $EPIX trade strongly tomorrow after $PFE disclosed as the lead order in their $40M follow-on"
X Link 2020-07-29T01:50Z [----] followers, [--] engagements
"$TLC and 3SBio Announce Acceptance of Marketing Authorization Application for Ampholipad in China https://www.globenewswire.com/news-release/2020/08/26/2083845/0/en/TLC-and-3SBio-Announce-Acceptance-of-Marketing-Authorization-Application-for-Ampholipad-in-China.html#.X0ZnMSMHhrM.twitter https://www.globenewswire.com/news-release/2020/08/26/2083845/0/en/TLC-and-3SBio-Announce-Acceptance-of-Marketing-Authorization-Application-for-Ampholipad-in-China.html#.X0ZnMSMHhrM.twitter"
X Link 2020-08-26T13:44Z [----] followers, [--] engagements
"$PINK.V adds Faxitron head of sales as their new Chief Commercial Officer. Faxitron now a $HOLX co sell breast cancer imaging tech so appears to be a logical fit for $PINK.V"
X Link 2020-09-01T12:49Z [----] followers, [--] engagements
"$XENE small block of [-----] went through this morn. They have been extremely quiet of late. We are expecting $NBIX IND milestone (XEN901 / NBI-921352) anytime & initiation of Ph3 for XEN496 this Q"
X Link 2020-10-01T12:52Z [----] followers, [--] engagements
"$XENE $NBIX announce delay in IND clearance for NBI-921352 in paediatric SCN8A-DEE patients due to FDA request for additional data on dose justification. Now guiding towards an IND in 2021"
X Link 2020-10-08T12:17Z [----] followers, [--] engagements
"After announcing a delay with their $NBIX partnered program $XENE follows up with 2nd PR this AM announcing their internal anti-epileptic asset XEN496 is on track to enter Ph3 in pediatric patients with KCNQ2-DEE before year-end"
X Link 2020-10-08T12:26Z [----] followers, [--] engagements
"$DCTH continues to recruit BTG alumni. 1st John Sylvester former BTG chief commercial officer joined the board. Now Kevin Muir ex BTG Director of Sales interventional oncology joins as VP commercial. BTG acquired by $BSX 2019"
X Link 2020-12-07T13:41Z [----] followers, [--] engagements
"$XENE update includes CEO transition initiation Ph3 XEN496 maintaining guidance topline Ph2b data 3Q21 XEN1101 new indication and study initiation XEN1101 1H21 full data XEN007 mid21 partners $NBIX starting Ph2 in adolescents 3Q21 XEN901 & $FLXN filing IND 1H21"
X Link 2021-01-14T13:14Z [----] followers, [--] engagements
"$XENE expects to have [--] studies (both proprietary and partnered) going in [----]. Proprietary; XEN1101 Ph2b focal epilepsy & Ph2 MDD XEN496 Ph3 KCNQ2 XEN007 Ph2 CAE. Partnered; $NBIX NBI-921352 Ph2 SCN8A & Ph2 focal epilepsy. $FLXN FX301 Ph1b bunionectomy"
X Link 2021-03-01T22:06Z [----] followers, [--] engagements
"$NBIX remains on track to initiate two studies with NBI-921352 Nav1.6 antagonist licensed from $XENE this year"
X Link 2021-05-05T20:22Z [----] followers, [--] engagements
"Social Capital makes CA$43.4 million investment into $PINK.V $PYNKF @chamath @PerimeterMed"
X Link 2021-12-15T15:09Z [----] followers, [--] engagements
"$LQDA $UTHR $MNKD"
X Link 2022-02-24T15:53Z [----] followers, [--] engagements
"We just published our latest podcast an interview with Jeb Besser of Manchester Mgmt ($100M AUM hedge fund). Jeb is also the CEO of insulin pump co $MODD. During the podcast we discuss MODD as well two of his favorite health care holdings $FENC & $ACOGF https://www.encodelp.com/podcasts/manchester-management/ https://www.encodelp.com/podcasts/manchester-management/"
X Link 2022-03-07T14:16Z [----] followers, [--] engagements
"The final health care co we discussed w Jeb Besser of Manchester Mgmt was an off-the-radar Alzheimer co $ACOGF $ACOG.V @alpha_cognition. Manchester led a $14M financing in Oct [--]. Besser explains why he prefers ACOG's pivotal BE study / 505(b)2 approach vs higher risk"
X Link 2022-03-08T15:26Z [----] followers, [--] engagements
"efficacy studies run by $BIIB $SAVA. Besser outlines why he thinks $ACOGF [----] a pro-drug of FDA-approved galantamine will report +ve BE data in Q2 supporting an NDA submission later this year. Besser explains why he thinks [----] will also demonstrate a superior tolerability"
X Link 2022-03-08T15:26Z [----] followers, [--] engagements
"As usual Brian @fin_capital is on top of the latest in the $LQDA $UTHR situation"
X Link 2022-03-10T23:59Z [----] followers, [--] engagements
"Our updated thoughts on $MODD here. Ironically MODD just filed an 8-K with a new deck that updates their 510(k) guidance to Q3 something we aren't surprised to see. $TNDM $PODD $MDT https://www.encodelp.com/coverage-updates/modular-medical-2/ https://www.encodelp.com/coverage-updates/modular-medical-2/"
X Link 2022-06-13T13:07Z [----] followers, [--] engagements
"Yesterday's Note "Update On A Few Names In Our Universe" $XENE $VRTX $CLRB $DCTH $ANEB $SKYE $NVO $VERU $VKTX $CGON $TARA $GANX https://www.encodelp.com/uncategorized/2024-universe-update/ https://www.encodelp.com/uncategorized/2024-universe-update/"
X Link 2024-02-12T13:38Z [----] followers, [----] engagements
""Rybelsus Redux: Entera Bio $ENTX & Oral GLP-1s For Obesity" $NVO $LLY $OPK $ALT $ZEAL $VTYX $ZVSA $SKYE"
X Link 2024-02-28T17:31Z [----] followers, [---] engagements
""A Binary Bet Worth Taking" $OPTN $NKTR $VTYX $ZVSA $SKYE $LLY"
X Link 2024-03-15T13:16Z [----] followers, [---] engagements
""A Little of Everything Pain $XENE Obesity $VERU Radiopharmaceuticals $CLRB and a High-Stakes Data Readout" $OPTN $NKTR $NGENF $NGEN.V https://www.encodelp.com/coverage-universe/april2024/ https://www.encodelp.com/coverage-universe/april2024/"
X Link 2024-04-04T12:42Z [----] followers, [----] engagements
"Entera $ENTX & Protara $TARA "Bones and Bladders" $IBRX $ENGN $CGON $LLY $AMGN https://www.encodelp.com/coverage-universe/etnx-tara/ https://www.encodelp.com/coverage-universe/etnx-tara/"
X Link 2024-04-29T12:41Z [----] followers, 12.9K engagements
""Watch out Dupixent Here Comes.Nektar $NKTR .Eupraxia $EPRX" $OPTN $LYRA $SLNO $VERU $SKYE https://www.encodelp.com/coverage-universe/nktr-eprx/ https://www.encodelp.com/coverage-universe/nktr-eprx/"
X Link 2024-05-09T12:52Z [----] followers, [---] engagements
""Optimism on Multiple Fronts" $DCTH $IMCR $ENTX $ASND $TARA $CGON $IBRX $OPTN https://www.encodelp.com/coverage-universe/may-2024/ https://www.encodelp.com/coverage-universe/may-2024/"
X Link 2024-05-28T13:06Z [----] followers, [----] engagements
"🙏 $LBPH $DRUG 01/15/24 https://www.encodelp.com/uncategorized/cellectar-clrb-delivers-at-jpm-and-a-newish-name/ Props to @encodelp for $DRUG https://www.encodelp.com/uncategorized/cellectar-clrb-delivers-at-jpm-and-a-newish-name/ Props to @encodelp for $DRUG"
X Link 2024-10-15T19:34Z [----] followers, [----] engagements
""Epilepsy's Hot Can $OVID Seize the Opportunity" $XENE $LBPH $DRUG https://www.encodelp.com/coverage-universe/ovid/ https://www.encodelp.com/coverage-universe/ovid/"
X Link 2024-11-07T13:43Z [----] followers, [----] engagements
""Protara $TARA Closing the Gap" $CGON $IBRX $ENGN @JNap5C https://www.encodelp.com/coverage-universe/tara-cybn/ https://www.encodelp.com/coverage-universe/tara-cybn/"
X Link 2024-11-15T14:07Z [----] followers, [----] engagements
"Dodging Data and Delays: FDA $CYBN $EPRX & $CLRB https://www.encodelp.com/coverage-universe/cybn-clrb-eprx/ https://www.encodelp.com/coverage-universe/cybn-clrb-eprx/"
X Link 2024-11-25T16:28Z [----] followers, [----] engagements
"$TARA "Protara $TARA Closing the Gap" $CGON $IBRX $ENGN @JNap5C https://t.co/Oiq9mL9J22 "Protara $TARA Closing the Gap" $CGON $IBRX $ENGN @JNap5C https://t.co/Oiq9mL9J22"
X Link 2024-12-05T15:10Z [----] followers, [---] engagements
"Protara $TARA Inserts Itself Into NMIBC Discussion $CGON $ENGN $PIRS @ByMadeleineA @BiotechCH https://www.encodelp.com/coverage-universe/protara-delivers/ https://www.encodelp.com/coverage-universe/protara-delivers/"
X Link 2024-12-09T14:14Z [----] followers, [---] engagements
"Soleno's PDUFA Push & Satellos' Ambitous DMD Plans $SLNO $APLT $MSCLF $MSCL.TO $SRPT @PropThinker https://www.encodelp.com/coverage-universe/slno-mscl/ https://www.encodelp.com/coverage-universe/slno-mscl/"
X Link 2024-12-18T14:51Z [----] followers, [---] engagements
"Trading Sideways: Better Days Ahead For Two Data-Rich Stories $VTYX $TARA https://www.encodelp.com/coverage-universe/vtyx-tara/ https://www.encodelp.com/coverage-universe/vtyx-tara/"
X Link 2025-01-23T14:04Z [----] followers, [---] engagements
"Near-Term Data Plump Balance Sheets & Calling It: Nektar Ventyx & Xenon $NKTR $VTYX $XENE @A_May_MD https://www.encodelp.com/coverage-universe/nktr-vtyx/ https://www.encodelp.com/coverage-universe/nktr-vtyx/"
X Link 2025-03-06T18:09Z [----] followers, [--] engagements
"Likeness: Bright Minds Delcath Novocure Trisalus.RenovoRx $DRUG $DCTH $NVCR $TLSI $RNXT https://www.encodelp.com/coverage-universe/rnxt/ https://www.encodelp.com/coverage-universe/rnxt/"
X Link 2025-03-24T13:23Z [----] followers, [--] engagements
"Franchise Building: Xenon & Delcath $XENE $DCTH https://www.encodelp.com/coverage-universe/april25/ https://www.encodelp.com/coverage-universe/april25/"
X Link 2025-04-16T13:01Z [----] followers, [--] engagements
"@jeangabcrevier @wardleworld BTD is clearly good news but there isn't a regulatory path forward without another big trial. That means more dilution or debt coming. Current B/S is a mess. They always seem to be able to find capital tho generally from strange sources. $RVXCF"
X Link 2020-02-25T17:18Z [----] followers, [--] engagements
"@jeangabcrevier @wardleworld I think $RVXCF will keep investors optimistic with false FDA hope. They always seem to find +ve data in failed studies"
X Link 2020-02-25T21:45Z [----] followers, [--] engagements
"How would you like to have a B/S like this in the current finance climate $RVXCF $RVX.TO Still sporting a CA$200M / US$150M cap"
X Link 2020-03-18T01:38Z [----] followers, [--] engagements
"@GantosJ curious to see how the stock reacts $APLIF $APLI.TO"
X Link 2021-05-17T12:47Z [----] followers, [--] engagements
"@GantosJ This outcome was the base case. Worse case = stopped futility. Best case = stopped efficacy & pursue EUA. In today's biotech tape not sure you get rewarded for base case news $APLIF $APLI.TO"
X Link 2021-05-17T13:08Z [----] followers, [--] engagements
"@excag Tough to argue with you on this. They executed so well on the front-end with favipiravir securing profit sharing for NA sales etc. But clinical execution has been underwhelming now Ph3 data could be behind $MRK"
X Link 2021-06-17T13:30Z [----] followers, [--] engagements
"$DCTH delivers strong FOCUS data into the teeth of the biotech bear $XBI. Improvement in ORR% from preliminary data release v. good duration of response and 1-yr survival is equivalent to $IMCR"
X Link 2021-12-02T13:39Z [----] followers, [--] engagements
"A few highlights from our interview with Jeb Besser of $MODD. Besser believes insulin pump market will follow the trend towards simplicity & affordability seen in adjacent CGM market. MODD copying playbook of $ABT Libre as it competes against pump giants $PODD $TNDM & $MDT"
X Link 2022-03-07T15:37Z [----] followers, [--] engagements
"This additional capital for $MODD should give them runway through 510k submission and clearance. A dedicated life science fund like Sio stepping up here is good to see too"
X Link 2022-05-03T15:55Z [----] followers, [--] engagements
"$ACOG.V $ACOGF reports ALPHA-1062 (pro-drug of #Alzheimer's drug galantamine) demonstrated BE with IR parent. Further CMC work needed before submitting 505(b)2 NDA in [----]. Earlier this year we did a podcast with PM Jeb Besser where he discussed ACOGF https://www.youtube.com/watchv=lwPWoXHri8A https://www.youtube.com/watchv=lwPWoXHri8A"
X Link 2022-06-22T13:18Z [----] followers, [--] engagements
"Protara's Small Sample But Big Potential & Rezolute's Rebound $TARA $CGON $RZLT https://www.encodelp.com/coverage-universe/protaras-small-sample-big-potential-rezolutes-rebound/ https://www.encodelp.com/coverage-universe/protaras-small-sample-big-potential-rezolutes-rebound/"
X Link 2025-05-01T14:35Z [----] followers, [----] engagements
"Decoding Q1: Insights on $XENE $DCTH $RNXT and $FENC https://www.encodelp.com/coverage-universe/decodingq125/ https://www.encodelp.com/coverage-universe/decodingq125/"
X Link 2025-05-19T14:23Z [----] followers, [----] engagements
"Expectations For Impending June Data From $NKTR $VTYX & $CMPS / $CYBN https://www.encodelp.com/coverage-universe/nktr-vtyx-cmps/ https://www.encodelp.com/coverage-universe/nktr-vtyx-cmps/"
X Link 2025-06-09T13:52Z [----] followers, [----] engagements
"$VRNA $DCTH $vrna just wow what a few years . i thought i was smart when it doubled // instead it went on to gain roughly 1380% after this rosalind capital to @encodelp verona pitch https://t.co/2Irlps5SKO $vrna just wow what a few years . i thought i was smart when it doubled // instead it went on to gain roughly 1380% after this rosalind capital to @encodelp verona pitch https://t.co/2Irlps5SKO"
X Link 2025-06-12T00:49Z [----] followers, [----] engagements
"Degrees of Good: Data From Nektar Compass and Ventyx $NKTR $CMPS $CYBN $VTYX https://www.encodelp.com/coverage-universe/nektar-ventyx/ https://www.encodelp.com/coverage-universe/nektar-ventyx/"
X Link 2025-07-02T15:50Z [----] followers, [----] engagements
"$VRNA Rosalind Dec [----] $VRNA novel MOA PDE3/4 inhibitor for COPD. Ph3 data mid-22. Good cash well-held big market. Gil Aharon of Rosalind highlights as a name they like & own. Feels strongly they hit on FEV1 less certain on QOL regardless feels affordable. Start [--] min mark https://t.co/gGSToJn65y $VRNA novel MOA PDE3/4 inhibitor for COPD. Ph3 data mid-22. Good cash well-held big market. Gil Aharon of Rosalind highlights as a name they like & own. Feels strongly they hit on FEV1 less certain on QOL regardless feels affordable. Start [--] min mark https://t.co/gGSToJn65y"
X Link 2025-07-09T11:55Z [----] followers, [----] engagements
"Ovid and Xenon: Too Early To Draw Parallels $OVID $XENE $DCTH https://www.encodelp.com/coverage-universe/ovid-dcth/ https://www.encodelp.com/coverage-universe/ovid-dcth/"
X Link 2025-07-17T14:55Z [----] followers, [----] engagements
"Patience Required: Delcath & RenovoRx $DCTH $RNXT https://www.encodelp.com/coverage-universe/delcath-renovorx/ https://www.encodelp.com/coverage-universe/delcath-renovorx/"
X Link 2025-08-25T12:54Z [----] followers, [----] engagements
"Proof of Concept FDA Alignment and Durability: Ovid Rezolute & Eupraxia $OVID $RZLT $EPRX https://www.encodelp.com/coverage-universe/proof-of-concept-fda-alignment-and-durability-ovid-rezolute-eupraxia/ https://www.encodelp.com/coverage-universe/proof-of-concept-fda-alignment-and-durability-ovid-rezolute-eupraxia/"
X Link 2025-09-03T13:45Z [----] followers, 10.5K engagements
"$OVID https://www.encodelp.com/coverage-universe/proof-of-concept-fda-alignment-and-durability-ovid-rezolute-eupraxia/ @TheBio_Hunter @encodelp wrote several excellent reports/updates on $OVID. I am long though commensurate in size w my aversion to binary outcomes. Reminds me too much of running to mailbox for college decisions https://www.encodelp.com/coverage-universe/proof-of-concept-fda-alignment-and-durability-ovid-rezolute-eupraxia/ @TheBio_Hunter @encodelp wrote several excellent reports/updates on $OVID. I am long though commensurate in size w my aversion to binary outcomes. Reminds"
X Link 2025-09-26T12:56Z [----] followers, [----] engagements
"Ovid's Data Parade & Eupraxia's Expansion $OVID $EPRX https://www.encodelp.com/coverage-universe/ovids-data-parade-eupraxias-expansion/ https://www.encodelp.com/coverage-universe/ovids-data-parade-eupraxias-expansion/"
X Link 2025-10-10T13:14Z [----] followers, [----] engagements
"$DCTH More Patience Required https://www.encodelp.com/coverage-universe/more-patience-required-delcath/ https://www.encodelp.com/coverage-universe/more-patience-required-delcath/"
X Link 2025-10-24T13:39Z [----] followers, [----] engagements
"Could A New Narrative Be Forming Protara & LMs $TARA $PVLA https://www.encodelp.com/coverage-universe/protara-lm/ https://www.encodelp.com/coverage-universe/protara-lm/"
X Link 2025-11-18T16:40Z [----] followers, [----] engagements
"Pipelines Partnerships And Predictions For [----] $TARA $OVID $EPRX $DCTH $VTYX $CYBN https://www.encodelp.com/coverage-universe/2026/ https://www.encodelp.com/coverage-universe/2026/"
X Link 2026-01-02T15:22Z [----] followers, [----] engagements
"$MSCL.TO $MSCLF Catch replay/transcript of DMD KOL call. Topics discussed: -challenges faced by gene therapy & exon skippers $SRPT $PTCT $WVE -how $MSCL $MSCLF is shifting treatment focus beyond dystrophin replacement -fit for unconventional approaches $CAPR $EWTX https://t.co/wWjmyB21OV Catch replay/transcript of DMD KOL call. Topics discussed: -challenges faced by gene therapy & exon skippers $SRPT $PTCT $WVE -how $MSCL $MSCLF is shifting treatment focus beyond dystrophin replacement -fit for unconventional approaches $CAPR $EWTX https://t.co/wWjmyB21OV"
X Link 2024-12-11T15:38Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing